Genetic mutation of recombination activating gene 1 in Dahl salt-sensitive rats attenuates hypertension and renal damage

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 304, Issue 6, 2013, Pages

  Mattson, David L ^a   Lund, Hayley ^a   Guo, Chuanling ^a   Rudemiller, Nathan ^a   Geurts, Aron M ^a   Jacob, Howard ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Albuminuria; B lymphocytes; Hypertension; Kidney disease; Recombination activating gene; T lymphocytes

Indexed keywords

ALBUMIN; NUCLEASE; RAG1 PROTEIN; SODIUM CHLORIDE; HOMEODOMAIN PROTEIN; RAG 1 PROTEIN; RAG-1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CELL ISOLATION; CIRCULATION; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; DNA RECOMBINATION; EMBRYO; FEMALE; FLOW CYTOMETRY; FRAMESHIFT MUTATION; GENE DELETION; GENE MUTATION; GENE TARGETING; GENETIC ASSOCIATION; GLOMERULAR DYSFUNCTION; GLOMERULUS; HISTOPATHOLOGY; HYPERTENSION; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CELL; KIDNEY INJURY; KIDNEY TUBULE DAMAGE; LYMPHOCYTIC INFILTRATION; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PRONUCLEUS; PSEUDOPREGNANCY; RAT; SPLEEN; T LYMPHOCYTE; THYMUS; URINARY EXCRETION; ANIMAL; BLOOD PRESSURE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; KIDNEY; KIDNEY DISEASE; METABOLISM; MUTATION; PATHOPHYSIOLOGY; SALT INTAKE;

ANIMALS; BLOOD PRESSURE; GENETIC PREDISPOSITION TO DISEASE; HOMEODOMAIN PROTEINS; HYPERTENSION; KIDNEY; KIDNEY DISEASES; MUTATION; RATS; RATS, INBRED DAHL; SODIUM CHLORIDE, DIETARY;

MLCS; MLOWN;

EID: 84877109327     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00304.2012     Document Type: Article

References (29)

1. Campese VM. Salt sensitivity in hypertension. Hypertension 23: 531-550, 1994.
2. Cowley AW Jr, Roman RJ. The role of the kidney in hypertension. JAMA 275:1581-1589, 1996.
3. De Miguel C, Das S, Lund H, Mattson DL. T-lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 298: R1136-R1142, 2010.
4. De Miguel C, Lund H, Di F, Mattson DL. Infiltrating T lymphocytes in the kidney increase oxidative stress and lead to hypertension and renal disease. Am J Physiol Renal Physiol 300: F734-F742, 2011.
5. De Miguel C, Lund H, Mattson DL. High dietary protein exacerbates hypertension and renal damage in Dahl salt-sensitive (SS) rats by increasing infiltrating immune cells. Hypertension 57: 269-274, 2011.
6. Feldman HI, Klag MJ, Chiapella AP, Whelton PK. End-stage renal disease in US minority groups. Am J Kidney Dis 19: 397-410, 1992.
7. Franco M, Martinez F, Quiroz Y, Galicia O, Bautista R, Johnson RJ, Rodriguez-Iturbe B. Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 293: R251-R256, 2007.
8. Geurts AM, Cost GJ, Remy S, Cui X, Tesson L, Usal C, Menoret S, Jacob HJ, Anegon I, Buelow R. Generation of gene-specific mutated rats using zinc-finger nucleases. Methods Mol Biol 597: 211-225, 2010.
9. Geurts AM, Cost GJ, Freyvert Y, Zeitler B, Miller JC, Choi VM, Jenkins SS, Wood A, Cui X, Meng X, Vincent A, Lam S, Michalkiewicz M, Schilling R, Foeckler J, Kalloway S, Weiler H, Ménoret S, Anegon I, Davis GD, Zhang L, Rebar EJ, Gregory PD, Urnov FD, Jacob HJ, Buelow R. Knockout rats via embryo microinjection of zinc-finger nucleases. Science 24: 433, 2009.
10. Grim CE, Wilson TW, Nicholson GD, Hassell TA, Fraser HS, Grim CM, Wilson DM. Blood pressure in blacks. Hypertension 15: 803-809, 1990.
11. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204: 2449-2460, 2007.
12. Herrera J, Ferrebuz A, García MacGregor E, Rodriguez-Iturbe B. Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis. J Am Soc Nephrol 17: 218-225, 2006.
13. Hughson Gobe GC MD, Hoy WE, Manning RD, Douglas-Denton R, Bertram JF. Associations of glomerular number and birth weight with clinicopathological features of African Americans and Whites. Am J Kidney Dis 52: 18-28, 2008.
14. Lackland DT, Keil JE. Epidemiology of hypertension in African Americans. Sem Nephrol 16: 63-70, 1996.
15. Mai M, Geiger H, Hilgens KF, Veelken R, Mann JFE, Daemmrich J, Luft FC. Early changes in hypertension induced renal injury. Hypertension 22: 754-765, 1993.
16. Mashimo T, Takizawa A, Voigt B, Yoshimi K, Hiai H, Kuramoto T, Serikawa T. Generation of knockout rats with x-linked severe combined immunodeficiency (x-scid) using zinc-finger nucleases. PLos One 5: e8870, 2010.
17. Mattson DL, James L, Berdan EA, Meister CJ. Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat. Hypertension 48: 149-156, 2006.
18. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. Rag-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877, 1992.
19. Moreno C, Hoffman M, Stodola TJ, Didier DN, Lazar J, Geurts AM, North PE, Jacob HJ, Greene AS. Creation and characterization of a renin knockout rat. Hypertension 57: 614-619, 2011.
20. Moreno C, Kennedy K, Andrae JW, Jacob HJ. Genome-wide scanning with SSLPs in the rat. Methods Mol Med 108: 131-138, 2005.
21. Muller DN, Shagdarsuren E, Park JK, Dechend R, Mervaala E, Hampich F, Fiebeler A, Ju X, Finckenberg P, Theuer J, Viedt C, Kreuzer J, Heidecke H, Haller H, Zenke M, Luft FC. Immunosuppressive treatment protects against Angiotensin II-induced renal damage. Am J Pathol 161: 1679-1693, 2002.
22. Pechman KR, Basile DP, Lund H, Mattson DL. Immune suppression blocks sodium-sensitive hypertension following recovery from ischemic acute renal failure. Am J Physiol Regul Integr Comp Physiol 294: R1234-R1239, 2008.
23. Quiroz Y, Pons H, Gordon KL, Rincón J, Chávez M, Parra G, Herrera-Acosta J, Gómez-Garre D, Larfo R, Egido J, Johnson RJ, Rodríguez-Iturbe B. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthase inhibition. Am J Physiol Renal Physiol 281: F38-F47, 2001.
24. Rodriguez-Iturbe B, Johnson RJ. The role of inflammatory cells in the kidney in the induction and maintenance of hypertension. Nephrol Dial Transplant 21: 260-263, 2006.
25. Rodríguez-Iturbe B, Pons H, Quiroz Y, Gordon K, Rincón J, Chávez M, Parra G, Herrera-Acosta J, Gomez-Garre D, Largo R, Egido J, Johnson RJ. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int 59: 2222-2232, 2001.
26. Seaberg EC, Muñoz A, Lu M, Detels R, Margolick JB, Riddler SA, Williams CM, Phair JP, Multicenter Cohort Study AIDS. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 19: 953-960, 2005.
27. Sommers SC, Relman AS, Smithwick RH. Histologic studies of kidney biopsy specimens from patients with hypertension. Am J Pathol 34: 685-715, 1958.
28. Stewart T, Jung FF, Manning J, Vehaskari VM. Kidney immune cell infiltration and oxidative stress contribute to prenatally programmed hypertension. Kidney Int 68: 2180-2188, 2005.
29. Zschemisch NH, Glage S, Wedekind D, Weinstein EJ, Cui X, Dorsch M, Hedrick HJ. Zinc finger nuclease mediated disruption of Rag1 in the LEW/Ztm rat. BMC Immunol 13:60, 2012.